HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patient factors predict periprosthetic fractures after revision total hip arthroplasty.

Abstract
We assessed important patient risk factors for postoperative periprosthetic fractures after revision total hip arthroplasty (THA) using prospectively collected Institutional Joint Registry data. We used univariate and multivariable-adjusted Cox regression analyses. There were 330 postoperative periprosthetic fractures after 6281 revision THAs. In multivariable-adjusted analyses, hazard ratio (95% confidence interval) of periprosthetic fracture was higher for women (1.66 [1.32-2.080], P < .001), a higher Deyo-Charlson comorbidity index of 2 (1.46 [1.03-2.07]) and index of 3+ (2.01 [1.48-2.73]; overall, P < .001), and operative diagnosis, especially previous nonunion (5.76 [2.55-13.02]; overall, P < .001). Hazard ratio was lower in patients 61 to 70 years old (0.64 [0.49-0.84]) and 71 to 80 years old (0.57 [0.43-0.76]) compared with those younger than 60 years (overall, P < .0001). Our study identified important modifiable and unmodifiable risk factors for fractures after revision THA.
AuthorsJasvinder A Singh, Matthew R Jensen, David G Lewallen
JournalThe Journal of arthroplasty (J Arthroplasty) Vol. 27 Issue 8 Pg. 1507-12 (Sep 2012) ISSN: 1532-8406 [Electronic] United States
PMID22342128 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightPublished by Elsevier Inc.
Topics
  • Aged
  • Aged, 80 and over
  • Arthroplasty, Replacement, Hip (adverse effects)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Periprosthetic Fractures (epidemiology, etiology)
  • Prognosis
  • Prospective Studies
  • Reoperation (adverse effects)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: